Angiodroid
ItalyEntry
2015
Hold
11yr
Status
Active
Who owns Angiodroid?
Angiodroid is an Italian MedTech company, currently owned by Aliad Venture Capital since 2022 and Origine SGR.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Origine SGRInnogest Capital II · 2015 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2015 · present
Origine SGRActive
2015 · present(11yr) · Innogest Capital II · 2015 · VC
Aliad Venture CapitalActive
2022 · present(4yr) · ALIAD · 2013 · VC
More from Innogest Capital II
Other portfolio companies in the same fund.
US
SpainMore PE-backed in MedTech
Comparable medtech deals from other GPs.
GermanyQuestions
Who owns Angiodroid?
Angiodroid is currently owned by Aliad Venture Capital and Origine SGR, through Innogest Capital II, since 2022.
When did Aliad Venture Capital and 1 other acquire Angiodroid?
Aliad Venture Capital and 1 other acquired Angiodroid in 2022.
Who has owned Angiodroid over time?
Angiodroid has been through 2 private-equity ownership periods: Origine SGR · via Innogest Capital II · since 2015; Aliad Venture Capital · via ALIAD · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue